Supplemental material Characteristics of patients with disease recurrence despite pathologic response

Published: 11 October 2024| Version 1 | DOI: 10.17632/sdysmjhrxp.1
Contributor:
Judith Versluis

Description

Supplemental material Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma

Files

Categories

Melanoma

Licence